Aiml Innovations Stock Net Income

AIMLF Stock  USD 0.07  0.01  24.53%   
AIML Innovations fundamentals help investors to digest information that contributes to AI/ML Innovations' financial success or failures. It also enables traders to predict the movement of AI/ML OTC Stock. The fundamental analysis module provides a way to measure AI/ML Innovations' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AI/ML Innovations otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AIML Innovations OTC Stock Net Income Analysis

AI/ML Innovations' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current AI/ML Innovations Net Income

    
  (3.17 M)  
Most of AI/ML Innovations' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AIML Innovations is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, AIML Innovations reported net income of (3.17 Million). This is 100.93% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The net income for all United States stocks is 100.56% higher than that of the company.

AI/ML Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AI/ML Innovations' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of AI/ML Innovations could also be used in its relative valuation, which is a method of valuing AI/ML Innovations by comparing valuation metrics of similar companies.
AIML Innovations is currently under evaluation in net income category among its peers.

AI/ML Fundamentals

About AI/ML Innovations Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AIML Innovations's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AI/ML Innovations using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AIML Innovations based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in AI/ML OTC Stock

AI/ML Innovations financial ratios help investors to determine whether AI/ML OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AI/ML with respect to the benefits of owning AI/ML Innovations security.